Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.97 USD | -4.50% | -11.06% | +146.88% |
May. 17 | Vera Therapeutics Insider Sold Shares Worth $1,304,435, According to a Recent SEC Filing | MT |
May. 10 | Wedbush Adjusts Vera Therapeutics' PT to $32 From $34, Keeps Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+146.88% | 2.08B | |
+64.23% | 62.59B | |
-2.31% | 41.18B | |
+43.79% | 40.29B | |
-8.29% | 27.9B | |
+11.97% | 26.21B | |
-21.16% | 19.09B | |
+7.54% | 13.08B | |
+27.17% | 12.05B | |
+25.72% | 12.26B |
- Stock Market
- Equities
- VERA Stock
- News Vera Therapeutics, Inc.
- Wedbush Downgrades Vera Therapeutics to Neutral From Outperform, Says Shares Likely Range-Bound in Near Term; Lowers PT to $8 From $33